Marinus Pharmaceuticals

OverviewSuggest Edit

Marinus Pharmaceuticals is a clinical stage biopharmaceutical company. It is engaged in the development and commercialization of ganaxolone. The Company develops treatments for patients suffering from drug-resistant seizures and neuropsychiatric disorders. 

TypePublic
Founded2003
HQWayne, US
Websitemarinuspharma.com

Latest Updates

Employees (est.) (Dec 2019)40(-2%)
Revenue (FY, 2016)$0
Share Price (Jun 2020)$2.5 (-4%)
Cybersecurity ratingAMore

Key People/Management at Marinus Pharmaceuticals

Scott Braunstein

Scott Braunstein

Chief Executive Officer & Director
Sasha Damouni Ellis

Sasha Damouni Ellis

VP, Investor Relations & Corporate Communications Marinus Pharmaceuticals, Inc.
Lisa M. Caperelli

Lisa M. Caperelli

Executive Director, Investor & Strategic Relations
Edward F. Smith

Edward F. Smith

Vice President, Chief Financial Officer, Secretary and Treasurer
Enrique J. Carrazana

Enrique J. Carrazana

Director
Joe Hulihan

Joe Hulihan

Chief Medical Officer
Show more

Marinus Pharmaceuticals Office Locations

Marinus Pharmaceuticals has an office in Wayne
Wayne, US (HQ)
170 N Radnor Chester Rd #250
Show all (1)

Marinus Pharmaceuticals Financials and Metrics

Marinus Pharmaceuticals Revenue

USD

Net income (Q1, 2020)

(18.7m)

EBIT (Q1, 2020)

(18.9m)

Market capitalization (29-Jun-2020)

264.0m

Closing stock price (29-Jun-2020)

2.5

Cash (31-Mar-2020)

70.3m

EV

196.6m
Marinus Pharmaceuticals's current market capitalization is $264 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

General and administrative expense

3.2m5.5m6.2m6.7m8.8m11.5m

R&D expense

8.7m18.9m22.0m12.4m28.4m43.0m

Operating expense total

11.9m24.4m28.3m19.0m37.2m54.4m
Quarterly
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

49.7m51.7m26.2m33.5m67.7m90.9m

Accounts Receivable

3.4m

Prepaid Expenses

978.0k1.2m2.5m

Inventories

428.0k1.6m199.0k
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(10.8m)(24.8m)(28.6m)(18.9m)(36.7m)(54.1m)

Depreciation and Amortization

5.0k11.0k23.0k126.0k127.0k278.0k

Inventories

39.0k278.9k

Accounts Payable

1.4m3.5m(629.0k)(2.1m)4.3m890.0k
USDQ2, 2014

Debt/Equity

-0.1 x

Debt/Assets

0.4 x

Financial Leverage

-0.1 x
Show all financial metrics

Marinus Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Marinus Pharmaceuticals Online and Social Media Presence

Embed Graph

Marinus Pharmaceuticals News and Updates

Marinus Pharmaceuticals to Present at SVB Leerink’s CybeRx Series: 2nd Annual CNS Forum

RADNOR, Pa., June 22, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced that management will present at SVB Leerink’s CybeRx Series: 2nd Annual CNS…

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

RADNOR, Pa., June 16, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (the “Company” or “Marinus”), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced the grant of an inducement award to a new empl…

Marinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock

RADNOR, Pa., May 28, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (“Marinus” or the “Company”), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced the pricing of an underwritten public offering …

Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial Results

Constructive End of Phase 2 Meeting with FDA for Status Epilepticus Completed in March; Pivotal Phase 3 Clinical Trial Expected to Begin Next Quarter

Marinus Pharmaceuticals Appoints Sasha Damouni Ellis as Vice President, Investor Relations and Corporate Communications

RADNOR, Pa., March 19, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat orphan seizure disorders, today announced the appointment of Sasha Damouni Ellis as Vice President, Investor Relat…

Marinus Pharmaceuticals Provides Business Reports Update and 2019 Financial Results

RADNOR, Pa., March 16, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today provided a business update on its clinical development activities and reported its f…
Show more

Marinus Pharmaceuticals Blogs

Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Content Import Mon, 07/30/2018 - 16:08 Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Jul 30, 2018 This release is a backfill fro…

Michael Higgins

Michael Higgins kenneth.beltra… Mon, 07/30/2018 - 10:00 Michael Higgins Ladenburg Thalmann

Elemer Piros, PhD

Elemer Piros, PhD kenneth.beltra… Mon, 07/30/2018 - 09:54 Elemer Piros, PhD Cantor Fitzgerald
Show more

Marinus Pharmaceuticals Frequently Asked Questions

  • When was Marinus Pharmaceuticals founded?

    Marinus Pharmaceuticals was founded in 2003.

  • Who are Marinus Pharmaceuticals key executives?

    Marinus Pharmaceuticals's key executives are Scott Braunstein, Sasha Damouni Ellis and Lisa M. Caperelli.

  • How many employees does Marinus Pharmaceuticals have?

    Marinus Pharmaceuticals has 40 employees.

  • Who are Marinus Pharmaceuticals competitors?

    Competitors of Marinus Pharmaceuticals include Intarcia Therapeutics, CureVac and GT Biopharma.

  • Where is Marinus Pharmaceuticals headquarters?

    Marinus Pharmaceuticals headquarters is located at 170 N Radnor Chester Rd #250, Wayne.

  • Where are Marinus Pharmaceuticals offices?

    Marinus Pharmaceuticals has an office in Wayne.

  • How many offices does Marinus Pharmaceuticals have?

    Marinus Pharmaceuticals has 1 office.